Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03158103
Recruitment Status : Active, not recruiting
First Posted : May 17, 2017
Last Update Posted : August 18, 2020
Sponsor:
Collaborators:
Array BioPharma
Plexxikon
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center